BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26546899)

  • 21. Potential role of soluble human leukocyte antigen-G molecules in multiple sclerosis.
    Fainardi E; Rizzo R; Castellazzi M; Stignani M; Granieri E; Baricordi OR
    Hum Immunol; 2009 Dec; 70(12):981-7. PubMed ID: 19651179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there a role for HLA-G in the induction of regulatory T cells during the maintenance of a healthy pregnancy?
    Al-Khunaizi NR; Tabbara KS; Farid EM
    Am J Reprod Immunol; 2020 Aug; 84(2):e13259. PubMed ID: 32352606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.
    Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Paolino E; Tola MR; Granieri E; Baricordi OR
    Mult Scler; 2006 Feb; 12(1):2-12. PubMed ID: 16459714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer.
    Chen HX; Lin A; Shen CJ; Zhen R; Chen BG; Zhang X; Cao FL; Zhang JG; Yan WH
    Hum Immunol; 2010 Sep; 71(9):892-8. PubMed ID: 20547193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis.
    Rizzo R; Pietrobon S; Mazzoni E; Bortolotti D; Martini F; Castellazzi M; Casetta I; Fainardi E; Di Luca D; Granieri E; Tognon M;
    J Transl Med; 2016 Jul; 14(1):216. PubMed ID: 27443345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.
    Ahmadian-Elmi M; Bidmeshki Pour A; Naghavian R; Ghaedi K; Tanhaei S; Izadi T; Nasr-Esfahani MH
    Immunogenetics; 2016 Jan; 68(1):43-54. PubMed ID: 26563334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma soluble human leukocyte antigen-G expression is a potential clinical biomarker in patients with hepatitis B virus infection.
    Shi WW; Lin A; Xu DP; Bao WG; Zhang JG; Chen SY; Li J; Yan WH
    Hum Immunol; 2011 Nov; 72(11):1068-73. PubMed ID: 21762747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis.
    McKay FC; Swain LI; Schibeci SD; Rubio JP; Kilpatrick TJ; Heard RN; Stewart GJ; Booth DR
    J Autoimmun; 2008 Aug; 31(1):52-8. PubMed ID: 18406576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis.
    Mikulkova Z; Praksova P; Stourac P; Bednarik J; Michalek J
    J Neurol Sci; 2011 Jan; 300(1-2):135-41. PubMed ID: 20884014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations.
    Praksova P; Stourac P; Bednarik J; Vlckova E; Mikulkova Z; Michalek J
    J Neurol Sci; 2012 Aug; 319(1-2):18-23. PubMed ID: 22676847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunomodulatory function of Treg-derived exosomes is impaired in patients with relapsing-remitting multiple sclerosis.
    Azimi M; Ghabaee M; Moghadasi AN; Noorbakhsh F; Izad M
    Immunol Res; 2018 Aug; 66(4):513-520. PubMed ID: 29882035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy.
    Saresella M; Marventano I; Longhi R; Lissoni F; Trabattoni D; Mendozzi L; Caputo D; Clerici M
    FASEB J; 2008 Oct; 22(10):3500-8. PubMed ID: 18587005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
    Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
    Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.
    Rebmann V; Lemaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
    Hum Immunol; 2005 Aug; 66(8):853-63. PubMed ID: 16216668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human leukocyte antigen (HLA)-G during pregnancy part I: correlations between maternal soluble HLA-G at midterm, at term, and umbilical cord blood soluble HLA-G at term.
    Klitkou L; Dahl M; Hviid TV; Djurisic S; Piosik ZM; Skovbo P; Møller AM; Steffensen R; Christiansen OB
    Hum Immunol; 2015 Apr; 76(4):254-9. PubMed ID: 25636573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T regulatory cells lacking CD25 are increased in MS during relapse.
    Fransson M; Burman J; Lindqvist C; Atterby C; Fagius J; Loskog A
    Autoimmunity; 2010 Dec; 43(8):590-7. PubMed ID: 20370571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease.
    Borghi A; Fogli E; Stignani M; Melchiorri L; Altieri E; Baricordi O; Rizzo R; Virgili A
    Arch Dermatol Res; 2008 Nov; 300(10):551-9. PubMed ID: 18797896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IFN-β induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis.
    Chen M; Chen G; Deng S; Liu X; Hutton GJ; Hong J
    J Neuroimmunol; 2012 Jan; 242(1-2):39-46. PubMed ID: 22112394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling.
    Schneider A; Long SA; Cerosaletti K; Ni CT; Samuels P; Kita M; Buckner JH
    Sci Transl Med; 2013 Jan; 5(170):170ra15. PubMed ID: 23363979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble HLA class I and class II antigens in patients with multiple sclerosis.
    Ott M; Seidl C; Westhoff U; Stecker K; Seifried E; Fischer PA; Grosse-Wilde H
    Tissue Antigens; 1998 Mar; 51(3):301-4. PubMed ID: 9550332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.